Wednesday, August 26
WASHINGTON, - U.S. President Donald Trump on Tuesday ordered a blockade of all sanctioned oil tankers entering and leaving Venezuela, a move set to sharply escalate tensions between Washington and Caracas. It is unclear how the Trump administration will impose the blockade against the sanctioned vessels, and whether he will turn to the Coast Guard to interdict vessels like he did last week. The administration has moved thousands of troops and nearly a dozen warships - including an aircraft carrier - to the region in recent months. "For the theft of our Assets, and many other reasons, including Terrorism, Drug Smuggling, and Human Trafficking, the Venezuelan Regime has been designated a FOREIGN TERRORIST ORGANIZATION," Trump wrote on Truth Social. "Therefore, today, I am ordering A TOTAL AN
Mutual fund managers adopted a relatively cautious approach in November, with the benchmark indices touching all-time highs, while the broader market struggled to keep pace with the blue chips. 126028422Private banks and NBFCs were among the top sector picks of the largest fund houses as they expect these to benefit from improving liquidity conditions. Fund managers added HDFC Bank, ICICI Bank, RBL Bank, Shriram Finance, L&T Finance, and M&M Financial. IT blue chips such as Infosys and TCS also saw buying interest from fund houses.
Novartis is deepening its presence in India, positioning the country as one of its most important global centres for biomedical research and drug development outside its headquarters in Basel, Switzerland.India is among the few markets where the Swiss drugmaker has established Biomedical Research alongside a full-spectrum development and operations footprint.The company, which operates the largest pharma GCC in India, has ramped up its workforce to strengthen early-stage research over the last one year to over 9,000 employees, which is about 11% of its global workforce, said a top company official.India-based teams now contribute to nearly every Novartis molecule that reaches late-stage development, spanning clinical operations, biostatistics, regulatory affairs and advanced analytics. The
